The 2022 edition of the IAS-USA drug resistance mutations list updates the Figure last published in September 2019. The mutations listed are those that have been identified by specific criteria for evidence and drugs described. The Figure is designed to assist practitioners to identify key mutations associated with resistance to antiretroviral drugs, and therefore, in making clinical decisions regarding antiretroviral therapy.
Wensing, A.m., Calvez, V., Ceccherini-Silberstein, F., Charpentier, C., Günthard, H.f., Paredes, R., et al. (2022). 2022 update of the drug resistance mutations in HIV-1. TOPICS IN ANTIVIRAL MEDICINE, 30(4), 559-574.
2022 update of the drug resistance mutations in HIV-1
Ceccherini-Silberstein, Francesca;
2022-01-01
Abstract
The 2022 edition of the IAS-USA drug resistance mutations list updates the Figure last published in September 2019. The mutations listed are those that have been identified by specific criteria for evidence and drugs described. The Figure is designed to assist practitioners to identify key mutations associated with resistance to antiretroviral drugs, and therefore, in making clinical decisions regarding antiretroviral therapy.File | Dimensione | Formato | |
---|---|---|---|
tam-30-559.pdf
solo utenti autorizzati
Tipologia:
Versione Editoriale (PDF)
Licenza:
Copyright dell'editore
Dimensione
229.47 kB
Formato
Adobe PDF
|
229.47 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.